Clonal cytotoxic T cells in myeloma (Q35614630)

9 August 2017

1 reference

title

Clonal cytotoxic T cells in myeloma (English)

1 reference

Barbara Fazekas De St Groth

9 August 2017

author

object named as

Barbara Fazekas de St Groth

9

0 references

author name string

Daniel M Y Sze

1

1 reference

9 August 2017

Ross D Brown

2

1 reference

9 August 2017

Edna Yuen

3

1 reference

9 August 2017

John Gibson

4

1 reference

9 August 2017

Joy Ho

5

1 reference

9 August 2017

Maria Raitakari

6

1 reference

9 August 2017

Antony Basten

7

1 reference

9 August 2017

Douglas E Joshua

8

1 reference

9 August 2017

publication date

1 October 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

44

1 reference

9 August 2017

issue

10

1 reference

9 August 2017

page(s)

1667-1674

1 reference

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Clonal rearrangement of immunoglobulin genes in the peripheral blood of multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Somatic rearrangement of T-cell antigen receptor gene in human T-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

A lectin-binding soluble factor released by CD8 CD57 lymphocytes from AIDS patients inhibits T cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8 T cells from HIV-infected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

The assessment of antigen-specific CD8 T cells through the combination of MHC class I tetramer and intracellular staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Memory CD8 T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Skewed maturation of memory HIV-specific CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Phenotypic and Functional Separation of Memory and Effector Human CD8 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

CD27 is required for generation and long-term maintenance of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Cancer vaccines and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Myeloma-reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8 T cell expansions are found preferentially in patients with a low tumor burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8 CD57 CD28 − compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

The prognostic significance of T cell receptor β gene rearrangements and idiotype-reactive T cells in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

CD8 /CD57 cells and apoptosis suppress T-cell functions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

CD57 /CD28- T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: evidence for systemic activation of the T cell compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Lymphocyte profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: flow-cytometric characterization and analysis in a two-dimensional correlation biplot

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Peripheral blood T lymphocytes in patients with monoclonal gammopathies: expanded subsets as depicted by capacity to bind to autologous monoclonal immunoglobulins or reactivity with anti-V gene-restricted antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Immunogenicity and cross‐reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Idiotype-specific T cells in multiple myeloma stage I: an evaluation by four different functional tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Low incidence of human herpesvirus 8 in stem cell collections from myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Idiotype immunity (natural and vaccine-induced) in early stage multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/1042819031000097438

10.1080/1042819031000097438

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference